Today, the CEO & Chairman of Opko Health (NASDAQ: OPK), Phillip Frost, bought shares of OPK for $85.25K.
Over the last month, Phillip Frost has reported another 9 Buy trades on OPK for a total of $598.1K. Following Phillip Frost’s last OPK Buy transaction on July 05, 2018, the stock climbed by 1.2%.
See today’s analyst top recommended stocks >>
Currently, Opko Health has an average volume of 4,100.
Eight different firms, including Barrington and Cantor Fitzgerald, currently also have a Buy rating on the stock.
The insider sentiment on Opko Health has been positive according to 107 insider trades in the past three months. This sentiment is slightly higher than the average sentiment of company insiders in this sector.
Company insider trades’ information is brought to you by the DailyInsider, a proprietary algorithm that analyzes insider trading activity to detect the most attractive trading opportunities. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
OPKO Health, Inc. engages in the provision of healthcare services. It operates through the Diagnostics and Pharmaceuticals segments. The Diagnostics segment comprises clinical laboratory operations which acquired through the Bio-Reference and point-of-care operations.
